Skip to main content Skip to main navigation menu Skip to site footer
Global Cardiology

eISSN 2975-2728

  • About the Journal
  • Editorial Board
  • Publication Ethics
  • Current
  • Archives
  • || New papers ||
  • Special Issues
    • Overview
  • Copyright & Licensing
  • Register
  • Login
  • Search
  • Contacts
  • News

Editor-in-Chief: Andrew J.S. Coats, Australia

Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • The scientific targets: the myocardium, the vasculature and the body’s response to heart failure

    Rafael Vidal-Pérez, Ewa A. Jankowska
    2024-03-28
    https://doi.org/10.4081/cardio.2024.19
    2654
    PDF: 202
    HTML: 21
  • Aldosterone synthase inhibitors in cardio-renal diseases: a state-of-the-art review

    Muhammad Hamza Dawood, Muhammad Shahzeb Khan, Ahmed Mustafa Rashid, Wilhelm Haverkamp
    2025-12-31
    https://doi.org/10.4081/cardio.2025.91
    21
    PDF: 4
  • Cardiac wasting in patients with advanced cancer: state of the art review

    Laibah Arshad Khan, Muhammad Shahzeb Khan, Rania Usman Latif, Markus S. Anker
    2025-04-16
    https://doi.org/10.4081/cardio.2025.65
    2391
    PDF: 478
    HTML: 38
  • Neck-to-height ratio in Bosnian university students according to the 2017 American College of Cardiology/American Heart Association guidelines on hypertension classification

    Asija Začiragić, Marija Mikić, Amela Dervišević, Orhan Lepara, Nesina Avdagić, Nermina Babić, Almir Fajkić, Amina Valjevac
    2024-03-28
    https://doi.org/10.4081/cardio.2024.27
    1874
    PDF: 218
    HTML: 12
  • Advanced cancer as a heart failure like syndrome due to cardiac wasting cardiomyopathy: facts and numbers

    Muhammad Shahzeb Khan, Javed Butler, Laibah Arshad Khan, Markus S. Anker
    2024-12-30
    https://doi.org/10.4081/cardio.2024.58
    3057
    PDF: 534
    HTML: 53
  • Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction

    Christian Basile, Stefan D. Anker, Gianluigi Savarese
    2025-07-16
    https://doi.org/10.4081/cardio.2025.76
    761
    PDF: 188
    Supplementary: 150
    Appendix: 105
    HTML: 34
  • Evolving targets for heart failure: the journey so far

    Giuseppe M.C. Rosano, Jerneja Farkas
    2023-11-28
    https://doi.org/10.4081/cardio.2023.6
    2009
    pdf: 321
    HTML: 4
  • Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction

    Christian Basile, Stefan D. Anker, Gianluigi Savarese
    2025-06-30
    https://doi.org/10.4081/cardio.2025.73
    752
    PDF: 211
    Supplementary: 142
    Appendix: 111
    HTML: 31
1 - 8 of 8 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge

reviewers

FOR REVIEWERS
  • How to Review

indexing

INDEXING
  • DOAJ
  • Google Scholar
  • OpenAlex
  • Scilit
  • Analytics

iCARDIO

May 1 marked the release of the #iCARDIO Guidelines on Heart Failure, now live in Global Cardiology. This global-first effort brings flexible, practical guidance to frontline providers managing #heartfailure in any setting. www.globalcardiology.info/site/article... #GlobalHealth #cardiosky

[image or embed]

— iCardio (@icardio.bsky.social) May 13, 2025 at 8:26

Keywords

Vol. 3 No. 4 (2025)
Effect of metformin and empagliflozin on myocardial function in insulin-resistant patients with heart failure: rationale and design of the...

Impaired energy metabolism contributed to clinical severity, disease progression and to outcome in heart failure (HF). Insulin sensitivity (IS) is a key metabolic factor in the control of energy substrate utilisation and energy efficiency in cardiac and skeletal muscle. Impaired IS, or insulin resistance, is a common finding in HF and has been shown to predict morbidity and mortality in patients with heart failure with reduced and mildly reduced ejection fraction (HFrEF, HFmrEF). Despite its pathophysiologic relevance, IS has not been...

Wolfram Doehner et al.
31 December 2025
Vol. 3 No. 4 (2025)
Aldosterone synthase inhibitors in cardio-renal diseases: a state-of-the-art review

Aldosterone plays a pivotal role in the progression of cardio-renal diseases by driving myocardial fibrosis, vascular dysfunction, and renal injury through both genomic and non-genomic mechanisms. While mineralocorticoid receptor antagonists have long served as the cornerstone of pharmacologic intervention, their use is limited by adverse effects such as hyperkalemia, gynecomastia, and incomplete suppression of aldosterone-mediated pathology. Aldosterone synthase inhibitors, a novel class of therapeutics, offer a promising alternative by...

Muhammad Hamza Dawood et al.
31 December 2025
Global Cardiology

is an Open Access, peer-reviewed journal published online by PAGEPress®, Pavia, Italy.
[Website continuously updated]

eISSN: 2975-2728

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

Themes by Openjournaltheme.com

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy